The Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) is receiving $23.3 million in federal funding in the fight against COVID-19.
With $11.3 million, officials said the Saskatoon research facility will be able to strengthen its existing expertise in coronavirus research and to help develop a vaccine for COVID-19.
An additional $12 million aims to help VIDO-InterVac expand its bio-manufacturing capacity to support clinical trials. “The $12 million enables us to build the facility to Good Manufacturing Practices standards as required for human vaccine production,” VIDO-InterVac director Volker Gerdts said in press release. “We expect to begin vaccine production in a little more than a year.” “InterVac